The collboration brings together four initiatives designed to address different barriers to ALS research. The ALS Society of ...
Two proteins in the panel, neurofilament light chain (NfL) and neurofilament heavy chain (NEFH), are well-established markers of nerve damage in ALS. Two others, pTau-181 and VEGFA, have also been ...
Lily Sander, national ambassador for the Muscular Dystrophy Association (MDA), hit on those themes in the opening talk at MDA ...
The experimental treatment AP-101 may help ALS patients preserve body weight, trial data show. Preservation of body weight is ...
ALS.Community has launched a new free online platform to help people with amyotrophic lateral sclerosis (ALS), their families ...
So many things in this world don’t have a cure, but compassion and care help.
A novel treatment for amyotrophic lateral sclerosis (ALS) caused by mutations in a specific gene called CHCHD10 showed promise for slowing disease progression in a clinical trial that tested the ...
Elevated blood levels of a marker of nerve damage known as NfL can be detected up to 15 years before an ALS diagnosis, a study found. The researchers say early detection using blood tests may help ...
A history of atherosclerotic cardiovascular disease (ASCVD) is linked to an increased risk of developing ALS, particularly among individuals aged 65 or younger. Better cardiovascular health is ...
Specialized multidisciplinary care was linked to longer survival in people with ALS. Limb-onset patients had 44 months of ventilation-free survival vs. 25 with general care. Researchers said the ...
I’ve been living with my husband Todd’s ALS for a long time, and while the disease is always there in the back of my mind, I’ve learned to compartmentalize it. I don’t want to talk about ALS all the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results